Novo Integrated Sciences Approves Increase Of Maximum Amount Under Stock Repurchase Program From $5M To $10M

Author: Benzinga Newsdesk | June 06, 2024 03:31pm

Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), today announced the Company's Board of Directors has approved an increase of up to $10 million maximum amount, from the previously announced up to $5 million maximum amount, for the repurchase of the Company's outstanding common stock from time to time in the open market at prevailing market prices or in privately negotiated transactions. The increased maximum amount available for purchase under the stock repurchase program is based on the amount, if any, of excess funds that may be generated from the pending program to monetize a Standby Letter of Credit intended to complete the Ophir Collection acquisition.

Posted In: NVOS